OncoCyte Corporation (OCX)
USD 2.2
(-0.45%)
USD 2.2
(-0.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -23.32 Million | -45.56 Million | -35.94 Million | -25.98 Million | -19.71 Million | -11.64 Million |
| Net Income | -27.78 Million | -72.9 Million | -64.09 Million | -29.93 Million | -22.42 Million | -15.75 Million |
| Depreciation & Amortization | 1.68 Million | 5.22 Million | 4.2 Million | 1.89 Million | 351 Thousand | 559 Thousand |
| Deferred income taxes | 8.1 Million | - | -9.26 Million | -1.25 Million | 483 Thousand | 956 Thousand |
| Stock-based compensation | 2.88 Million | 10.04 Million | 6.84 Million | 5.06 Million | 2.99 Million | 1.47 Million |
| Change in working capital | -3.97 Million | -1.94 Million | -2.2 Million | 399 Thousand | -1.55 Million | 993 Thousand |
| Other non-cash items | -4.24 Million | 14.01 Million | 28.57 Million | -2.15 Million | 437 Thousand | 118 Thousand |
| Investing Cash Flow | -932 Thousand | -4.34 Million | -13.96 Million | -11.74 Million | -12.41 Million | -31 Thousand |
| Investments in PPE | -281 Thousand | -4.34 Million | -2.24 Million | -1.22 Million | -918 Thousand | -31 Thousand |
| Acquisitions | 354 Thousand | - | -11.71 Million | -10.51 Million | -11.24 Million | - |
| Investment purchases | -354 Thousand | - | - | -4 Million | -11.24 Million | - |
| Sales/Maturities of investments | 367 Thousand | - | - | 4 Million | 11.24 Million | - |
| Other Investing Activities | -1.01 Million | -4.34 Million | -13.35 Million | -7000.00 | -252 Thousand | -240 Thousand |
| Financing Cash Flow | 12.18 Million | 35.8 Million | 78.36 Million | 22.79 Million | 47.86 Million | 12.11 Million |
| Debt repayment | -117 Thousand | -1.42 Million | -1.53 Million | -446 Thousand | -1.63 Million | -1.18 Million |
| Dividends payments | - | - | - | - | - | -96 Thousand |
| Common Stock Repurchased | -1.11 Million | - | -239 Thousand | -14 Thousand | - | - |
| Common Stock Issuance | 13.42 Million | 37.23 Million | 80.52 Million | 20.8 Million | 48.85 Million | 13.29 Million |
| Other Financing Activities | 12.3 Million | 37.23 Million | 80.13 Million | 5.04 Million | 655 Thousand | 13.29 Million |
| Accounts receivables | 109 Thousand | -575 Thousand | -1.22 Million | -182 Thousand | - | - |
| Accounts payables | -4.75 Million | 297 Thousand | -1.34 Million | 854 Thousand | 741 Thousand | 1 Million |
| Inventory | 784 Thousand | - | - | - | - | - |
| Other working capital | -107 Thousand | -1.66 Million | 373 Thousand | -273 Thousand | -2.29 Million | -9000.00 |
| Cash at beginning of period | 23.2 Million | 37.3 Million | 8.84 Million | 23.77 Million | 8.03 Million | 7.6 Million |
| Cash at end of period | 11.13 Million | 23.2 Million | 37.3 Million | 8.84 Million | 23.77 Million | 8.03 Million |
| Capital Expenditure | -281 Thousand | -4.34 Million | -2.24 Million | -1.22 Million | -918 Thousand | -31 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -12.07 Million | -14.1 Million | 28.46 Million | -14.92 Million | 15.73 Million | 434 Thousand |
| Free Cash Flow | -23.6 Million | -49.9 Million | -38.18 Million | -27.2 Million | -20.63 Million | -11.68 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.53 Million | -9.12 Million | -15.99 Million | -27.78 Million | -6.48 Million | -8.33 Million |
| Depreciation & Amortization | 326 Thousand | 335 Thousand | 325 Thousand | 1.68 Million | 426 Thousand | 457 Thousand |
| Deferred income taxes | - | - | 65 Thousand | 8.1 Million | 1.9 Million | 24 Thousand |
| Stock-based compensation | 436 Thousand | 464 Thousand | 611 Thousand | 2.88 Million | 608 Thousand | 834 Thousand |
| Change in working capital | -1.17 Million | 1.01 Million | -510 Thousand | -3.97 Million | 113 Thousand | -1.6 Million |
| Other non-cash items | 1.22 Million | 3.43 Million | 10.93 Million | -4.24 Million | 1.18 Million | 1.79 Million |
| Investing Cash Flow | -191 Thousand | -24 Thousand | 241 Thousand | -932 Thousand | -1.29 Million | 123 Thousand |
| Investments in PPE | -191 Thousand | -24 Thousand | -264 Thousand | -281 Thousand | -17 Thousand | - |
| Acquisitions | - | - | -354 Thousand | 354 Thousand | 231 Thousand | 123 Thousand |
| Investment purchases | - | - | - | -354 Thousand | - | - |
| Sales/Maturities of investments | - | - | 367 Thousand | 367 Thousand | - | - |
| Other Investing Activities | - | -24 Thousand | 138 Thousand | -1.01 Million | -1.51 Million | 123 Thousand |
| Financing Cash Flow | 9.84 Million | - | -30 Thousand | 12.18 Million | -30 Thousand | 12.27 Million |
| Debt repayment | -33 Thousand | - | -30 Thousand | -117 Thousand | -30 Thousand | -29 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -5.38 Million | - | 1.11 Million | -1.11 Million | - | -1.11 Million |
| Common Stock Issuance | 15.26 Million | - | -13.42 Million | 13.42 Million | - | 13.42 Million |
| Other Financing Activities | 9.84 Million | - | -30 Thousand | 12.3 Million | -30 Thousand | 12.3 Million |
| Accounts receivables | 76 Thousand | 323 Thousand | -21 Thousand | 109 Thousand | -166 Thousand | 185 Thousand |
| Accounts payables | -1.24 Million | 854 Thousand | -564 Thousand | -4.75 Million | 126 Thousand | -1.65 Million |
| Inventory | - | - | 139 Thousand | 784 Thousand | - | - |
| Other working capital | -15 Thousand | -158 Thousand | -64 Thousand | -107 Thousand | 153 Thousand | -137 Thousand |
| Cash at beginning of period | 5.57 Million | 9.43 Million | 15.48 Million | 23.2 Million | 19.06 Million | 13.5 Million |
| Cash at end of period | 9.25 Million | 5.57 Million | 11.13 Million | 11.13 Million | 15.48 Million | 19.06 Million |
| Capital Expenditure | -191 Thousand | -24 Thousand | -264 Thousand | -281 Thousand | -17 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.67 Million | -3.85 Million | -4.35 Million | -12.07 Million | -3.58 Million | 5.56 Million |
| Free Cash Flow | -6.16 Million | -3.85 Million | -4.82 Million | -23.6 Million | -2.27 Million | -6.83 Million |
0JTQ
0Y5X
LINDEINDIA
3485
OKYO
FAS